[HTML][HTML] Medical care costs of cancer in the last year of life using national health insurance data in Korea

M Park, I Song - PLoS one, 2018 - journals.plos.org
Background Medical care of cancer patients at the end-of-life is costly. This study aims to
describe the monthly trends of EOL medical care, drug therapy, and chemotherapy costs per …

Impact of inpatient radiation on length of stay and health care costs.

S Pintova, RF Holcombe… - The Journal of Community …, 2015 - europepmc.org
Background Health care costs are rising. Identifying areas for health care utilization savings
may reduce costs. Objective To identify oncology patients receiving inpatient radiotherapy …

[PDF][PDF] Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a sixmonth episode: an economic analysis from the payer …

B Sagar, YS Lin, LD Castel - J Med Econ, 2017 - academia.edu
Aims: In the absence of clinical data, accurate identification of cost drivers is needed for
economic comparison in an alternate payment model. From a payer perspective using …

Associations between end-of-life cancer care patterns and Medicare expenditures

SY Wang, J Hall, CE Pollack, K Adelson… - Journal of the National …, 2016 - jnccn.org
Background: The purpose of this study was to examine the extent to which patterns of
intensive end-of-life care explain geographic variation in end-of-life care expenditures …

Cost drivers for breast, lung, and colorectal cancer care in a commercially insured population over a 6-month episode: an economic analysis from a health plan …

B Sagar, YS Lin, LD Castel - Journal of Medical Economics, 2017 - Taylor & Francis
Aims: In the absence of clinical data, accurate identification of cost drivers is needed for
economic comparison in an alternate payment model. From a health plan perspective using …

Cost of care for elderly cancer patients in the United States

KR Yabroff, EB Lamont, A Mariotto… - Journal of the …, 2008 - academic.oup.com
Background Timely estimates of the costs of care for cancer patients are an important
element in the formulation of national cancer programs and policies. We estimated net costs …

Assessing reliability of quality measures across oncology practices: Implications for value-based payment.

RA Bromley-Dulfano, MB Landrum, GA Brooks… - 2023 - ascopubs.org
4 Background: Identifying reliable measures that distinguish care quality at the medical
oncology practice level is crucial to ensuring delivery of high-value cancer care, particularly …

Assessing Medicare's approach to covering new drugs in bundled payments for oncology

LD Muldoon, PM Pelizzari, KA Lang, J Vandigo… - Health …, 2018 - healthaffairs.org
New oncology therapies can contribute to survival or quality of life, but payers and policy
makers have raised concerns about the cost of these therapies. Similar concerns extend …

Evaluating the addition of clinical and staging data to improve the pricing methodology of the oncology care model

TRF Dreyer, E Hamilton, A Dahl, B Desai… - JCO Oncology …, 2022 - ascopubs.org
PURPOSE: The Oncology Care Model (OCM) is the largest value-based care model
focusing on oncology, but the current pricing methodology excludes relevant data on the …

Cost of disease progression in patients with metastatic breast, lung, and colorectal cancer

C Reyes, NM Engel‐Nitz, S DaCosta Byfield… - The …, 2019 - academic.oup.com
Introduction To reduce health care costs and improve care, payers and physician groups are
piloting value‐based and episodic or bundled‐care payment models in oncology. Disease …